HHS weighs rescinding Moderna bird flu vaccine contract
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Moderna's bird flu vaccine has a problem
A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...
Moderna Stock Falls on Report HHS Is Reviewing Bird Flu Vaccine Contract
Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...
Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Moderna slides on report of Trump team reevaluating bird flu vaccine funding
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...
Rolling Out5d
What to know about the latest vaccine updates
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
STAT1d
Pharmalittle: We’re reading about a cancelled FDA vaccine meeting, a Moderna bird flu vaccine, and more
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
The Taipei Times2d
Children’s COVID-19 vaccines used up: CDC
The JN.1-adapted COVID-19 vaccines for children aged six months to 11 years have been used up, so starting from yesterday, ...
Moderna stock falls amid review of bird flu vaccine funds
Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...